BFS-project: Identifying genetic mechanisms of resistance to chemotherapy in human cancer
Department: Department of Clinical Science
Dr. Stian Knappskog completed his engineers education in 1999 and his MSc in 2003. He has since then been focusing his research on the molecular and genetic mechanisms causing some cancer cells to become resistant to chemotherapy. He completed his PhD in 2007 and has performed post doctoral work at the University of Bergen and the Wellcome Trust Sanger Institute, Cambridge, UK.
He has held several major grants from the Norwegian Research Council, the Norwegian Cancer Society and the Norwegian Health Region West. In 2016 he received the young scientist of the year – award by the Norwegian Oncology forum, and is currently a Senior Research Fellow at the University of Bergen and laboratory manager of the Mohn Cancer Research Laboratory.
VG 14.08.2017 Norske forskere med nytt gjennombrudd: Kan gi bedre behandling av brystkreft
BA 14.08.2017 Bergensforskere med kreftgjenombrudd
Express 14.08.2017 Breast cancer breakthrough: THIS finding could stop disease spreading and saves lives
Medical Xpress 14.08.2017 New study reveals late spread of breast cancer and backs key role of early diagnosis
Dagens Medisin 18.11.2016 Stian Knappskog får pris for genforskning